Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer

D. Kelsen, R. Gralla, M. Stoopler, E. Casper, E. Cheng, C. Kosloff, R. Golbey

Research output: Contribution to journal › Article › peer-review